Literature DB >> 25529173

Motor and non-motor symptoms of Parkinson's disease and their impact on quality of life and on different clinical subgroups.

K Berganzo1, B Tijero2, A González-Eizaguirre2, J Somme3, E Lezcano2, I Gabilondo2, M Fernandez2, J J Zarranz2, J C Gómez-Esteban2.   

Abstract

INTRODUCTION: The aim of the present study is to analyse the influence that motor and non-motor symptoms have on the quality of life (QoL) of patients with Parkinson's disease (PD), and to study the relationship between the two types of symptoms.
MATERIAL AND METHODS: This cross-sectional study included 103 patients with PD (55 men and 48 women). Quality of life was measured on the PDQ-39 scale. The UPDRS scale (I-IV) was also used, and different items were grouped to analyse the presence of tremor, rigidity, bradykinesia, and axial symptoms. The non-motor symptoms scale (NMSS) was administered to assess non-motor symptoms. We performed correlation analyses between different scales to analyse the influence of motor and non-motor symptoms on QoL.
RESULTS: Correlations were observed between the PDQ-39 summary index (PDQ39_SI) and the NMSS (correlation coefficient [cc], 0.56; p<.001), UPDRS III (cc, 0.44; p< .001) and UPDRS IV (cc, 0.37; p<.001) scores. The strongest correlation was between cognitive symptoms and mood. The analysis pointed to a direct relationship between the NMSS score and axial symptoms (cc, 0.384; p<.01), bradykinesia (cc, 0.299; p<.01), and to a lesser extent, rigidity (cc, 0.194; p<.05). No relationship was observed between presence of tremor and the NMSS score.
CONCLUSION: Cognitive symptoms and mood exert the most influence on QoL of patients with PD. We found at least two phenotypes; one with predominantly axial symptoms, with significant involvement of non-motor symptoms, and a tremor-associated phenotype in which these symptoms are less prevalent.
Copyright © 2014 Sociedad Española de Neurología. Publicado por Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Calidad de vida; Enfermedad de Parkinson; NMSS scale; Non-motor symptoms scale; Parkinson's disease; Quality of life

Mesh:

Year:  2014        PMID: 25529173     DOI: 10.1016/j.nrl.2014.10.010

Source DB:  PubMed          Journal:  Neurologia        ISSN: 0213-4853            Impact factor:   3.109


  28 in total

1.  Assessment of Duodopa® effects on quality of life of patients with advanced Parkinson's disease and their caregivers.

Authors:  Rosella Ciurleo; Francesco Corallo; Lilla Bonanno; Viviana Lo Buono; Giuseppe Di Lorenzo; Roberta Versaci; Cettina Allone; Rosanna Palmeri; Placido Bramanti; Silvia Marino
Journal:  J Neurol       Date:  2018-06-27       Impact factor: 4.849

2.  Association of three candidate genetic variants in RAB7L1/NUCKS1, MCCC1 and STK39 with sporadic Parkinson's disease in Han Chinese.

Authors:  Ling Wang; Lan Cheng; Zhong-Jiao Lu; Xiao-Yi Sun; Jun-Ying Li; Rong Peng
Journal:  J Neural Transm (Vienna)       Date:  2016-02-25       Impact factor: 3.575

Review 3.  The Effect of Deep Brain Stimulation on Swallowing Function in Parkinson's Disease: A Narrative Review.

Authors:  Min Cheol Chang; Jin-Sung Park; Byung Joo Lee; Donghwi Park
Journal:  Dysphagia       Date:  2021-01-02       Impact factor: 3.438

Review 4.  Effects of dance therapy on non-motor symptoms in patients with Parkinson's disease: a systematic review and meta-analysis.

Authors:  Li-Li Wang; Cai-Jie Sun; Yan Wang; Ting-Ting Zhan; Juan Yuan; Cong-Ying Niu; Jie Yang; Shan Huang; Ling Cheng
Journal:  Aging Clin Exp Res       Date:  2022-01-29       Impact factor: 3.636

Review 5.  Role of SARS-CoV-2 in Modifying Neurodegenerative Processes in Parkinson's Disease: A Narrative Review.

Authors:  Jeremy M Morowitz; Kaylyn B Pogson; Daniel A Roque; Frank C Church
Journal:  Brain Sci       Date:  2022-04-22

6.  Cerebrovascular responses to somatomotor stimulation in Parkinson's disease: A multivariate analysis.

Authors:  Sam C Barnes; Ronney B Panerai; Lucy Beishon; Martha Hanby; Thompson G Robinson; Victoria J Haunton
Journal:  J Cereb Blood Flow Metab       Date:  2022-03-15       Impact factor: 6.960

7.  Association of Motor and Nonmotor Symptoms With Health-Related Quality of Life in a Large Online Cohort of People With Parkinson Disease.

Authors:  Meredith A Bock; Ethan G Brown; Li Zhang; Caroline Tanner
Journal:  Neurology       Date:  2022-04-13       Impact factor: 11.800

Review 8.  Technology in Parkinson's disease: Challenges and opportunities.

Authors:  Alberto J Espay; Paolo Bonato; Fatta B Nahab; Walter Maetzler; John M Dean; Jochen Klucken; Bjoern M Eskofier; Aristide Merola; Fay Horak; Anthony E Lang; Ralf Reilmann; Joe Giuffrida; Alice Nieuwboer; Malcolm Horne; Max A Little; Irene Litvan; Tanya Simuni; E Ray Dorsey; Michelle A Burack; Ken Kubota; Anita Kamondi; Catarina Godinho; Jean-Francois Daneault; Georgia Mitsi; Lothar Krinke; Jeffery M Hausdorff; Bastiaan R Bloem; Spyros Papapetropoulos
Journal:  Mov Disord       Date:  2016-04-29       Impact factor: 10.338

9.  Heterogeneous Determinants of Quality of Life in Different Phenotypes of Parkinson's Disease.

Authors:  Seyed-Mohammad Fereshtehnejad; Mahdiyeh Shafieesabet; Farzaneh Farhadi; Hasti Hadizadeh; Arash Rahmani; Nader Naderi; Dena Khaefpanah; Gholam Ali Shahidi; Ahmad Delbari; Johan Lökk
Journal:  PLoS One       Date:  2015-09-03       Impact factor: 3.240

10.  Patterns of grey matter loss associated with motor subscores in early Parkinson's disease.

Authors:  Xingfeng Li; Yue Xing; Antonio Martin-Bastida; Paola Piccini; Dorothee P Auer
Journal:  Neuroimage Clin       Date:  2017-11-10       Impact factor: 4.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.